Literature DB >> 910821

Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome.

R G Harper, G Solish, E Feingold, N B Gersten-Woolf, M M Sokal.   

Abstract

The relationship between the quantity of methadone ingested by the pregnant mother, the quantity of methadone in maternal and neonatal body fluids, and the subsequent neonatal withdrawal course was studied. The severity of the neonatal withdrawal syndrome was found to be related to the total dose of methadone ingested by the mother during the last 12 weeks of pregnancy (p less than 0.02), the maternal dose of methadone at delivery (p less than 0.01), and the intrapartum serum methadone levels (p less than 0.01). The cord blood levels of methadone were consistently lower than the maternal serum levels. Amniotic fluid methadone levels were not constantly related to maternal or neonatal serum methadone levels. Concentrations of methadone 10 to 60 times greater than that of cord blood were found in neonatal urine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910821     DOI: 10.1016/0002-9378(77)90588-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns.

Authors:  C O'Brien; R Hunt; H E Jeffery
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

Review 2.  Detoxification considerations in the medical management of substance abuse in pregnancy.

Authors:  M H Allen
Journal:  Bull N Y Acad Med       Date:  1991 May-Jun

3.  Hyperphagia in neonates withdrawing from methadone.

Authors:  A Martinez; B Kastner; H W Taeusch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

4.  Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.

Authors:  Ana de Castro; Hendreé E Jones; Rolley E Johnson; Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-08       Impact factor: 3.681

5.  Infant autonomic functioning and neonatal abstinence syndrome.

Authors:  Lauren M Jansson; Janet A Dipietro; Andrea Elko; Martha Velez
Journal:  Drug Alcohol Depend       Date:  2010-03-01       Impact factor: 4.492

6.  [Addiction--who is not affected?].

Authors:  Andjela Bäwert; Gabriele Fischer
Journal:  Wien Med Wochenschr       Date:  2005-12

7.  Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.

Authors:  Teresa R Gray; Robin E Choo; Marta Concheiro; Erica Williams; Andrea Elko; Lauren M Jansson; Hendreé E Jones; Marilyn A Huestis
Journal:  Addiction       Date:  2010-09-20       Impact factor: 6.526

8.  Congenital hypothyroidism and neonatal withdrawal syndrome.

Authors:  P Bahwere; D Haumont; F Delange
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

9.  Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?

Authors:  C A Kuschel; L Austerberry; M Cornwell; R Couch; R S H Rowley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.